Hummer Law Offices: 10333 Seminole Blvd. Suite 14, Largo, Florida 33778. Phone: 727-397-9198
Hummer Law Offices is a licensed Florida attorney for defective medical products in Tampa Bay, Florida. Our law office represents registered claimants in the Settlement For Dow Corning Trust (SFDCT)- DC Settlement - Dow Corning Breast Implants Settlement - Hip Implant Recall - Knee Implant Recall - Merina - Actos - Fosmas & Boniva - Byetta, Januvia, & Janumet - GranFlo - NaturalLyte - Lipitor - Testosterone - Viagra- Xarelto - Yaz, Yasmin and Ocella Litigation Attorneys - Kugel Hernia Mesh Patch - Infusion Pumps - Pain Pumps - Asbestos - GM Ignition Switch Litigation Lawyer In Pinellas County, Florida - Attorney For Social Security Disability In Largo, Seminole, St. Petersburg, Tampa, FL If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, please contact us concerning copyright matters.
Expedited Release Checks Important Please Read The Settlement Facility Dow Corning Trust has recently decided to send Expedited Release Payments ($2,000) to all claimants whose cases are idle. The Dow Settlement criteria states that if you accept this payment you can NEVER apply for a disease claim in the future, even if you become sick. If you receive one of these checks in the mail, please do not cash it until you speak with an attorney to discuss your potential claim. Again, if you cash this check you have effectively settled your claim and can never get any additional money.
SFDCT Medical Criteria Learn about the medical criteria that you will need to meet in order to submit a disease claim through the SFDCT Settlement.
A claim for SLE must include a diagnosis of SLE (lupus) made by a Board-certified rheumatologist based upon personal examination of the patient. [Exclusion: mild lupus (SLE not requiring regular medical attention including doctor visits and regular prescription medications).]
Supporting medical documentation must affirmatively reveal that at least four (4) of the following eleven (11) criteria are present:
Malar rash Fixed erythema, flat or raised, over the malar eminences, tending to spare the nasolabial folds.
Discoid rash Erythematous raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring may occur in older lesions.
Photosensitivity Skin rash as a result of unusual reaction to sunlight, by patient history or physician observation
Oral ulcers Oral or nasopharyngeal ulceration, usually painless, observed by a physician.
Arthritis Nonerosive arthritis involving two or more peripheral joints, characterized by tenderness, swelling, or effusion. [Exclusion: erosive arthritis]
Pleuritis -- convincing history of pleuritic pain or rub heard by a physician or evidence of pleural effusion, or
Pericarditis -- documented by ECG or rub or evidence of pericardial effusion.
Persistent proteinuria greater than 0.5 grams per day or greater than three (3)+ if quantitation not performed, or
Cellular casts -- may be red cell, hemoglobin, granular, tubular, or mixed.
Neurologic disorder Seizures -- in the absence of offending drugs or known metabolic derangements, e.g. uremia, ketoacidosis, or electrolyte imbalance.
Hemolytic anemia -- with reticulocytosis, or
Leukopenia -- less than 4,000/mm total on two (2) or more occasions, or
Lymphopenia -- less than 1,500/mm on two (2) or more occasions, or
Thrombocytopenia -- less than 100,000/mm in the absence of offending drugs.
Positive LE cell preparation, or
Anti-DNA: antibody to native DNA in abnormal titer, or
Anti-Sm: presence of antibody to Sm nuclear antigen, or
False positive serologic test for syphilis known to be positive for at least 6 months and confirmed by Treponema pallidum immobilization or fluorescent treponemal antibody absorption test
Anti-SS-A (Sjogrens blood-work)
Antinuclear antibody An abnormal titer or antinuclear antibody by immunofluorescence or an equivalent assay at any point in time and in the absence of drugs known to be associated with "drug-induced lupus" syndrome.
Death resulting from SLE, or severe chronic renal involvement manifested by a glomerular filtration rate of less than 50% of the age- and gender-adjusted norm, as measured by an adequate 24-hour urine specimen collection.
SLE with involvement of one (1) or more of the following: glomerulonephritis, seizures in the absence of offending drugs or known metabolic derangements, Lupus Psychosis, myocarditis, pneumonitis, thrombocytopenic purpura, hemolytic anemia (with hemoglobin of 10 grams or less), severe granulocytopenia (with a total white cell count less than 2000), or mesenteric vasculitis.
A diagnosis of lupus in accordance with the above criteria that does not involve the findings in A or B above. (Default compensation level.)